Navigation Links
Perrigo Announces FDA Final Approval Of Tris Pharma's Dextromethorphan Polistirex Extended-Release Oral Suspension
Date:5/30/2012

ALLEGAN, Mich., May 30, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that the U.S. Food and Drug Administration has granted final approval to Tris Pharma for its abbreviated new drug application (ANDA) for Dextromethorphan Polistirex Extended-Release Oral Suspension, the store brand equivalent to Reckitt Benckiser's Delsym® suspension. As the exclusive marketer and distributor of this product for the store brand over-the-counter (OTC) market in the United States, Perrigo expects to begin shipping its product during its first fiscal quarter of 2013.

(Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO)

Litigation between Tris and Reckitt Benckiser is ongoing in the United States District Court for the District of New Jersey, where the court has previously granted summary judgment of non-infringement of the asserted patent claims. As the Tris ANDA was the first one submitted with a paragraph IV certification, marketing of the product is entitled to 180 days of generic exclusivity.

Delsym® is indicated for the treatment of cough due to minor throat and bronchial irritation. Perrigo estimates the past 52-weeks sales for the brand were approximately $110 million.

Perrigo's Chairman and CEO Joseph C. Papa stated, "This approval further highlights our ability to bring new products to our consumers and reinforces our continued focus of making quality healthcare more affordable. We are pleased to add this important new product to our retail and wholesale customers' store brand product portfolios when we begin shipments to them for the upcoming cough/cold/flu season."

Tris Pharma is a technology driven specialty pharmaceutical company which pioneered sustained release in liquid and other unique dosage forms such as chewable/ODT and film strip.

Perrigo Company is a leading global healthcare supplier that develops,
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
2. Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules
3. Perrigo Company to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference
4. Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance
5. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
6. Perrigo Company to Present at the RBC Capital Markets Healthcare Conference
7. Perrigo Announces the Launch of Loratadine-D 12 Store Brand Labels -- the First Store Brand Launch That Compares to Claritin-D® 12
8. Perrigo Company to Present at the Leerink Swann 2012 Global Healthcare Conference
9. Perrigo Company Announces Quarterly Dividend
10. Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals
11. Perrigo Wins Summary Judgment in Generic Mucinex® Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 2015 According to a new ... Technology (RF, Microwave, Cryoablation, Others), Department (Interventional Radiology, Surgery, ... Metastasis) - Global Forecasts to 2019", published by MarketsandMarkets, ... $462.0 Million growing at a CAGR of 11.50% by ... 57 figures spread through 195 pages and in-depth TOC ...
(Date:3/26/2015)... , March 26, 2015  CCS Medical ("CCS"), ... medical supplies for patients with chronic conditions, has ... Chief Executive Officer, effective March 23.  Mr. Carson ... company, where he was President of Operations. ... President and Executive Vice President of Operations at ...
(Date:3/26/2015)... 26, 2015  Desert Valley Medical Center, named a ... is the first U.S. hospital to deploy the ... to help clinicians prevent hospital acquired pressure ulcers. ... , is a community hospital serving some higher ... Leaf Patient Monitor in the hospital,s emergency department enables ...
Breaking Medicine Technology:Tumor Ablation Market Worth $462.0 Million by 2019 2Tumor Ablation Market Worth $462.0 Million by 2019 3Tumor Ablation Market Worth $462.0 Million by 2019 4CCS Medical Team Hires Industry Operator Rodney Carson as CEO 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3
... landmark trial provide important insight for physicians in treating ... Corporation (NYSE: BSX ) today welcomed the ... this week,s issue of the New England Journal of ... Cardiovascular Research Foundation with research grant support from Boston ...
... over linezolid in resistance acquisition by Staph aureus ... meetingSAN DIEGO, Calif., May 6 Trius Therapeutics, ... the treatment of serious bacterial infections, announced today ... lead program, torezolid (TR-701), will be presented in ...
Cached Medicine Technology:Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 2Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 3Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 4Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 5Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases 2Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases 3
(Date:3/26/2015)... Tarrytown, NY (PRWEB) March 26, 2015 ... conducted its 30th “Introduction to Hyperbaric Medicine” course, ... Hyperbaric Medical Society (UHMS) and the National Board ... LST provides the 40-hour course 4 times a ... facilities around the NY tri-state region; registration is ...
(Date:3/26/2015)... 26, 2015 On March 5, 2015, ... is out for the season with a torn Achilles ... the Trail Blazers were competing against Dallas, and was ... specialist, Izzy Silva, M.D., who has treated many professional ... whether it could be prevented. , "Part of ...
(Date:3/26/2015)... 2015 Volunteers will collectively walk hundreds ... disease and funds to support the American Parkinson ... – Find the Cure. The Optimism Walk ... in more than 20 locations including, Boston, Chicago, Connecticut, ... Antonio, Minnesota, Seattle, St. Louis, New York, Nevada, South ...
(Date:3/26/2015)... Hartford, CT (PRWEB) March 26, 2015 ... Connecticut State Capitol Building to help celebrate the achievement ... a groundbreaking employment program serving some 500 people. , ... by The WorkPlace in partnership with the ... coach and prepare long-term unemployed workers and place them ...
(Date:3/26/2015)... The beauty industry united on Saturday, March ... revolutionized the business of beauty education. The Beauty Changes ... Pivot Point International, Inc. Passage’s wife Lenie, and son ... at the Art Institute of Chicago, the sold-out event ... media leaders and served as the signature gala event ...
Breaking Medicine News(10 mins):Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 2Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 4Health News:American Parkinson Disease Association 2015 Optimism Walk Season Launches Nationwide 2Health News:CRN International Shows Support For Groundbreaking Connecticut Program To Aid The Unemployed 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 3
... replicate damaged DNA could dramatically enhance the effectiveness of ... pair of papers from MIT biologists. In studies ... specific system for tolerating DNA damage not only prolonged ... to chemotherapy, and made tumors much less likely to ...
... health in the eyes of diabetic mice has researchers wanting to ... the same for people. "We want to know if this ... occur with diabetes," said Dr. Sylvia Smith, retinal cell biologist and ... Georgia. "That means we need to know more about how and ...
... is available in French . , A fundamental ... doctors who treat breast cancer, this is easier said than ... breast cancer their treatment usually involves surgery to remove ... cancer returning. But studies show that for most patients with ...
... -- A solar-powered blood-pressure measuring device that,s reliable and affordable ... low-income nations, according to a new study. Field tests ... and one in Zambia -- showed that the $32 automated ... testing method for systolic blood pressure, which is the top ...
... 8 (HealthDay News) -- U.S. physicians, links with drug ... decreased since 2004, but many doctors still have ties ... survey found that about four out of five doctors ... their workplaces and more than 75 percent were given ...
... PICK: PIT(-1)ting good and bad outcomes against each other in ... cancer is determined in part by whether or not their ... team of researchers, led by Roman Perez-Fernandez and colleagues, at ... in a subset of patients with breast cancer, a marker ...
Cached Medicine News:Health News:Massachusetts Institute of Technology IDs new cancer drug target 2Health News:Potential drug therapy for diabetic retinopathy under study 2Health News:Potential drug therapy for diabetic retinopathy under study 3Health News:Breast cancer: Reducing the risk of unnecessary chemo 2Health News:Solar Blood-Pressure Device Shows Promise for Use in Poor Nations 2Health News:Fewer U.S. Docs Accepting Perks From Industry: Survey 2Health News:JCI online early table of contents: Nov. 8, 2010 2Health News:JCI online early table of contents: Nov. 8, 2010 3Health News:JCI online early table of contents: Nov. 8, 2010 4Health News:JCI online early table of contents: Nov. 8, 2010 5
CritiCool™ offers precise cooling to the programmed target temperature by applying temperature control algorithm....
Inquire...
Whole blood tube use for microbiology...
BD Vacutainer® Specialty Tubes - Other - Glass...
Medicine Products: